XML 19 R8.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2024 0          
Beginning balance at Dec. 31, 2024 $ 0          
Ending balance (in shares) at Jun. 30, 2025 0          
Ending balance at Jun. 30, 2025 $ 0          
Beginning balance (in shares) at Dec. 31, 2024   85,568,000        
Beginning balance at Dec. 31, 2024 2,183,243 $ 8,628 $ 1,824,935 $ 526,642 $ (19,095) $ (157,867)
Shareholders' Equity            
Comprehensive income (loss) 113,711     74,151   39,560
Stock-based compensation expense 6,996   6,996      
Common stock transactions related to stock-based employee benefit plans (in shares)   380,000        
Common stock transactions related to stock-based employee benefit plans (1,425) $ 45 227   (1,697)  
Dividends on common stock (30,960)     (30,960)    
Increase (decrease) in shares during period (in shares)   380,000        
Increase (decrease) in stockholders' equity during period 88,322 $ 45 7,223 43,191 (1,697) 39,560
Ending balance (in shares) at Jun. 30, 2025   85,948,000        
Ending balance at Jun. 30, 2025 $ 2,271,565 $ 8,673 1,832,158 569,833 (20,792) (118,307)
Beginning balance (in shares) at Mar. 31, 2025 0          
Beginning balance at Mar. 31, 2025 $ 0          
Ending balance (in shares) at Jun. 30, 2025 0          
Ending balance at Jun. 30, 2025 $ 0          
Beginning balance (in shares) at Mar. 31, 2025   85,618,000        
Beginning balance at Mar. 31, 2025 2,229,740 $ 8,633 1,828,234 542,665 (19,072) (130,720)
Shareholders' Equity            
Comprehensive income (loss) 55,100     42,687   12,413
Stock-based compensation expense 3,958   3,958      
Common stock transactions related to stock-based employee benefit plans (in shares)   330,000        
Common stock transactions related to stock-based employee benefit plans (1,714) $ 40 (34)   (1,720)  
Dividends on common stock (15,519)     (15,519)    
Increase (decrease) in shares during period (in shares)   330,000        
Increase (decrease) in stockholders' equity during period 41,825 $ 40 3,924 27,168 (1,720) 12,413
Ending balance (in shares) at Jun. 30, 2025   85,948,000        
Ending balance at Jun. 30, 2025 $ 2,271,565 $ 8,673 1,832,158 569,833 (20,792) (118,307)
Beginning balance (in shares) at Dec. 31, 2025 11,250          
Beginning balance at Dec. 31, 2025 $ 343,125          
Ending balance (in shares) at Jun. 30, 2026 11,250          
Ending balance at Jun. 30, 2026 $ 343,125          
Beginning balance (in shares) at Dec. 31, 2025 97,927,843 97,928,000        
Beginning balance at Dec. 31, 2025 $ 2,712,662 $ 9,873 2,197,549 603,793 (21,358) (77,195)
Shareholders' Equity            
Comprehensive income (loss) 84,555     91,430   (6,875)
Stock-based compensation expense 10,000   10,000      
Common stock transactions related to stock-based employee benefit plans (in shares)   (35,000)        
Common stock transactions related to stock-based employee benefit plans (1,648) $ 5 962   (2,615)  
Repurchase of common stock (in shares)   (1,070,000)        
Repurchase of common stock (33,164)       (33,164)  
Dividends on common stock (37,325)     (37,325)    
Dividends on preferred stock (4,275)     (4,275)    
Increase (decrease) in shares during period (in shares)   (1,105,000)        
Increase (decrease) in stockholders' equity during period $ 18,143 $ 5 10,962 49,830 (35,779) (6,875)
Ending balance (in shares) at Jun. 30, 2026 96,822,799 96,823,000        
Ending balance at Jun. 30, 2026 $ 2,730,805 $ 9,878 2,208,511 653,623 (57,137) (84,070)
Beginning balance (in shares) at Mar. 31, 2026 11,000          
Beginning balance at Mar. 31, 2026 $ 343,125          
Ending balance (in shares) at Jun. 30, 2026 11,250          
Ending balance at Jun. 30, 2026 $ 343,125          
Beginning balance (in shares) at Mar. 31, 2026   97,665,000        
Beginning balance at Mar. 31, 2026 2,717,650 $ 9,878 2,202,879 614,853 (31,373) (78,587)
Shareholders' Equity            
Comprehensive income (loss) 54,052     59,535   (5,483)
Stock-based compensation expense 5,520   5,520      
Common stock transactions related to stock-based employee benefit plans (in shares)   (90,000)        
Common stock transactions related to stock-based employee benefit plans (2,488)   112   (2,600)  
Repurchase of common stock (in shares)   (752,000)        
Repurchase of common stock (23,164)       (23,164)  
Dividends on common stock (18,628)     (18,628)    
Dividends on preferred stock (2,137)     (2,137)    
Increase (decrease) in shares during period (in shares)   (842,000)        
Increase (decrease) in stockholders' equity during period $ 13,155 $ 0 5,632 38,770 (25,764) (5,483)
Ending balance (in shares) at Jun. 30, 2026 96,822,799 96,823,000        
Ending balance at Jun. 30, 2026 $ 2,730,805 $ 9,878 $ 2,208,511 $ 653,623 $ (57,137) $ (84,070)